Join Growin Stock Community!

圓點奈米6797.TW Overview

TW StockBiotech. & Medical
(No presentation for 6797)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

圓點奈米（6797）Overall Performance

圓點奈米（6797）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

圓點奈米（6797） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

圓點奈米（6797）Key Information

圓點奈米（6797）Profile

Taiwan Advanced Nanotech Inc. designs and manufactures products for nucleic acid purification. The company's products include reagent kits, which are used in DNA/RNA extractions from samples of blood, cell, tissue, plant, bacteria, virus, etc.; magnetic nanoparticles, including super-paramagnetic iron oxide and ultra small super-paramagnetic iron oxide for molecular biology applications; automated extraction instruments; and consumables, such as spin tips and deep well plates. It offers its products to disease control centers, testing institutions, hospitals, and other related facilities. The company was founded in 2004 and is based in Taoyuan, Taiwan.

圓點奈米（6797）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-13.37
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.08
PB Ratio
0.51
Price-to-FCF
1.37
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-13.69%
Net Margin
-98.33%
Revenue Growth (YoY)
-68.51%
Profit Growth (YoY)
-108.80%
3-Year Revenue Growth
-56.69%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-13.37
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
1.08
PB Ratio
0.51
Price-to-FCF
1.37
Gross Margin
-13.69%
Net Margin
-98.33%
Revenue Growth (YoY)
-68.51%
Profit Growth (YoY)
-108.80%
3-Year Revenue Growth
-56.69%
3-Year Profit Growth
-%
default symbol

6797

圓點奈米

14.70D

-4.08%

(-0.04)

  • When is 6797's latest earnings report released?

    The most recent financial report for 圓點奈米 (6797) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 6797's short-term business performance and financial health. For the latest updates on 6797's earnings releases, visit this page regularly.

  • How much cash does 6797 have?

    At the end of the period, 圓點奈米 (6797) held Total Cash and Cash Equivalents of 226.13M, accounting for 0.17 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 6797 go with three margins increasing?

    In the latest report, 圓點奈米 (6797) did not achieve the “three margins increasing” benchmark, with a gross margin of -37.57%%, operating margin of -157.32%%, and net margin of -181.18%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 6797's profit trajectory and future growth potential.